<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">26616193</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>11</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-3088</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2016</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Trends in cell biology</Title>
          <ISOAbbreviation>Trends Cell Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs.</ArticleTitle>
        <Pagination>
          <StartPage>190</StartPage>
          <EndPage>201</EndPage>
          <MedlinePgn>190-201</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tcb.2015.10.013</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0962-8924(15)00215-9</ELocationID>
        <Abstract>
          <AbstractText>AMP-activated protein kinase (AMPK) is a key regulator of energy balance expressed ubiquitously in eukaryotic cells. Here we review the canonical adenine nucleotide-dependent mechanism that activates AMPK when cellular energy status is compromised, as well as other, noncanonical activation mechanisms. Once activated, AMPK acts to restore energy homeostasis by promoting catabolic pathways, resulting in ATP generation, and inhibiting anabolic pathways that consume ATP. We also review the various hypothesis-driven and unbiased approaches that have been used to identify AMPK substrates and have revealed substrates involved in both metabolic and non-metabolic processes. We particularly focus on methods for identifying the AMPK target recognition motif and how it can be used to predict new substrates.</AbstractText>
          <CopyrightInformation>Copyright © 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hardie</LastName>
            <ForeName>D Grahame</ForeName>
            <Initials>DG</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK. Electronic address: d.g.hardie@dundee.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schaffer</LastName>
            <ForeName>Bethany E</ForeName>
            <Initials>BE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Genetics and the Cancer Biology Program, Stanford University, 300 Pasteur Drive, Stanford, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brunet</LastName>
            <ForeName>Anne</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Genetics and the Cancer Biology Program, Stanford University, 300 Pasteur Drive, Stanford, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>T32 CA009302</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01AG031198</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>C37030/A15101</GrantID>
            <Agency>Cancer Research UK</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>P01 AG036695</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>097726</GrantID>
            <Agency>Wellcome Trust</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AG031198</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <Agency>Wellcome Trust</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>T32CA09302</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2015</Year>
          <Month>11</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Trends Cell Biol</MedlineTA>
        <NlmUniqueID>9200566</NlmUniqueID>
        <ISSNLinking>0962-8924</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 2.7.11.31</RegistryNumber>
          <NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000494" MajorTopicYN="N">Allosteric Regulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020134" MajorTopicYN="N">Catalytic Domain</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AMPK</Keyword>
        <Keyword MajorTopicYN="N">allosteric activation</Keyword>
        <Keyword MajorTopicYN="N">energy sensing</Keyword>
        <Keyword MajorTopicYN="N">kinase recognition motif</Keyword>
        <Keyword MajorTopicYN="N">kinase target identification</Keyword>
        <Keyword MajorTopicYN="N">pharmacological activators</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2015</Year>
          <Month>8</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2015</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2015</Year>
          <Month>10</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2015</Year>
          <Month>12</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2015</Year>
          <Month>12</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>11</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">26616193</ArticleId>
        <ArticleId IdType="mid">NIHMS740767</ArticleId>
        <ArticleId IdType="pmc">PMC5881568</ArticleId>
        <ArticleId IdType="doi">10.1016/j.tcb.2015.10.013</ArticleId>
        <ArticleId IdType="pii">S0962-8924(15)00215-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hardie DG. AMPK--sensing energy while talking to other signaling pathways. Cell Metab. 2014;20:939–952.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5693325</ArticleId>
            <ArticleId IdType="pubmed">25448702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oakhill JS, et al.  AMPK functions as an adenylate charge-regulated protein kinase. Trends Endocrinol. Metab. 2012;23:125–132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22284532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carling D, et al.  AMP-activated protein kinase: new regulation, new roles? Biochem. J. 2012;445:11–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22702974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley SA, et al.  Characterization of the AMP-activated protein kinase kinase from rat liver, and identification of threonine-172 as the major site at which it phosphorylates and activates AMP-activated protein kinase. J. Biol. Chem. 1996;271:27879–27887.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8910387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oakhill JS, et al.  AMPK is a direct adenylate charge-regulated protein kinase. Science. 2011;332:1433–1435.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21680840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao B, et al.  Structure of mammalian AMPK and its regulation by ADP. Nature. 2011;472:230–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3078618</ArticleId>
            <ArticleId IdType="pubmed">21399626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gowans GJ, et al.  AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation. Cell Metab. 2013;18:556–566.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3791399</ArticleId>
            <ArticleId IdType="pubmed">24093679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, et al.  Structural basis of AMPK regulation by adenine nucleotides and glycogen. Cell Res. 2015;25:50–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4650587</ArticleId>
            <ArticleId IdType="pubmed">25412657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott JW, et al.  CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest. 2004;113:274–284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC311435</ArticleId>
            <ArticleId IdType="pubmed">14722619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao B, et al.  Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature. 2007;449:496–500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17851531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L, et al.  AMP-activated protein kinase undergoes nucleotide-dependent conformational changes. Nat. Struct. Mol. Biol. 2012;19:716–718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22659875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao B, et al.  Structural basis of AMPK regulation by small molecule activators. Nature Commun. 2013;4:3017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3905731</ArticleId>
            <ArticleId IdType="pubmed">24352254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calabrese MF, et al.  Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms. Structure. 2014;22:1161–1172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25066137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pang T, et al.  Conserved alpha-helix acts as autoinhibitory sequence in AMP-activated protein kinase alpha subunits. J. Biol. Chem. 2007;282:495–506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17088252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goransson O, et al.  Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J. Biol. Chem. 2007;282:32549–32560.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2156105</ArticleId>
            <ArticleId IdType="pubmed">17855357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crute BE, et al.  Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J. Biol. Chem. 1998;273:35347–35354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9857077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L, et al.  Structural insight into the autoinhibition mechanism of AMP-activated protein kinase. Nature. 2009;459:1146–1149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19474788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor SS, Kornev AP. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem. Sci. 2011;36:65–77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3084033</ArticleId>
            <ArticleId IdType="pubmed">20971646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xin FJ, et al.  Coordinated regulation of AMPK activity by multiple elements in the alpha-subunit. Cell Res. 2013;23:1237–1240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3790237</ArticleId>
            <ArticleId IdType="pubmed">23999859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez-Galeno JE, et al.  A potent and selective AMPK activator that inhibits de novo lipogenesis. ACS Med. Chem. Lett. 2010;1:478–482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4007905</ArticleId>
            <ArticleId IdType="pubmed">24900234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter RW, et al.  Mechanism of action of Compound-13: an alpha1-selective small molecule activator of AMPK. Chem. Biol. 2014;21:866–879.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4104029</ArticleId>
            <ArticleId IdType="pubmed">25036776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riek U, et al.  Structural properties of AMP-activated protein kinase. Dimerization, molecular shape, and changes upon ligand binding. J. Biol. Chem. 2008;283:18331–18343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18372250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang CS, et al.  The lysosomal v-ATPase-Ragulator complex Is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 2014;20:526–540.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25002183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang YL, et al.  AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation. Cell Metab. 2013;18:546–555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24093678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corton JM, et al.  5-Aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 1995;229:558–565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7744080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cool B, et al.  Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 2006;3:403–416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16753576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanders MJ, et al.  Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family. J. Biol. Chem. 2007;282:32539–32548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17728241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hudson ER, et al.  A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Current Biol. 2003;13:861–866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12747836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polekhina G, et al.  AMPK b-Subunit targets metabolic stress-sensing to glycogen. Current Biol. 2003;13:867–871.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12747837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai YC, et al.  A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators. Biochem. J. 2014;460:363–375.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24665903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley SA, et al.  The ancient drug salicylate directly activates AMP-activated protein kinase. Science. 2012;336:918–922.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3399766</ArticleId>
            <ArticleId IdType="pubmed">22517326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langendorf CG, Kemp BE. Choreography of AMPK activation. Cell Res. 2015;25:5–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4650591</ArticleId>
            <ArticleId IdType="pubmed">25475061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley SA, et al.  Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005;2:9–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16054095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woods A, et al.  Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005;2:21–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16054096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hurley RL, et al.  The Ca2+/calmoldulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 2005;280:29060–29066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15980064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fogarty S, et al.  Calmodulin-dependent protein kinase kinase-beta activates AMPK without forming a stable complex - synergistic effects of Ca2+ and AMP. Biochem. J. 2010;426:109–118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2830670</ArticleId>
            <ArticleId IdType="pubmed">19958286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley SA, et al.  Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. 2010;11:554–565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2935965</ArticleId>
            <ArticleId IdType="pubmed">20519126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee YS, et al.  Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006;55:2256–2264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16873688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang SL, et al.  Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia. 2012;55:1469–1481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22095235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baur JA, et al.  Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337–342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4990206</ArticleId>
            <ArticleId IdType="pubmed">17086191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Racanelli AC, et al.  Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition. Cancer Res. 2009;69:5467–5474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2706929</ArticleId>
            <ArticleId IdType="pubmed">19549896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pirkmajer S, et al.  Methotrexate promotes glucose uptake and lipid oxidation in skeletal muscle via AMPK activation. Diabetes. 2015;64:360–369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5703413</ArticleId>
            <ArticleId IdType="pubmed">25338814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weekes J, et al.  Specificity determinants for the AMP-activated protein kinase and its plant homologue analysed using synthetic peptides. FEBS Lett. 1993;334:335–339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7902296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davies SP, et al.  Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. Eur. J. Biochem. 1989;186:123–128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2574667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dale S, et al.  Similar substrate recognition motifs for mammalian AMP-activated protein kinase, higher plant HMG-CoA reductase kinase-A, yeast SNF1, and mammalian calmodulin-dependent protein kinase I. FEBS Lett. 1995;361:191–195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7698321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott JW, et al.  Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and a model substrate. J. Mol. Biol. 2002;317:309–323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11902845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Istvan ES, et al.  Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J. 2000;19:819–830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC305622</ArticleId>
            <ArticleId IdType="pubmed">10698924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gwinn DM, et al.  AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell. 2008;30:214–226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2674027</ArticleId>
            <ArticleId IdType="pubmed">18439900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Songyang Z, et al.  Use of an oriented peptide library to determine the optimal substrates of protein kinases. Current Biol. 1994;4:973–982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7874496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banko MR, et al.  Chemical genetic screen for AMPKalpha2 substrates uncovers a network of proteins involved in mitosis. Mol. Cell. 2011;44:878–892.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3246132</ArticleId>
            <ArticleId IdType="pubmed">22137581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habelhah H, et al.  Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue. J. Biol. Chem. 2001;276:18090–18095.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11259409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah K, Shokat KM. A chemical genetic screen for direct v-Src substrates reveals ordered assembly of a retrograde signaling pathway. Chem. Biol. 2002;9:35–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11841937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blethrow JD, et al.  Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates. Proc. Natl. Acad. Sci. USA. 2008;105:1442–1447.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2234163</ArticleId>
            <ArticleId IdType="pubmed">18234856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schaffer BE, et al.  Identification of AMPK phosphorylation sites reveals a network of proteins involved in cell invasion and facilitates large-scale substrate prediction. Cell Metabolism. 2015 in press.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4635044</ArticleId>
            <ArticleId IdType="pubmed">26456332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yaffe MB, et al.  The structural basis for 14-3-3:phosphopeptide binding specificity. Cell. 1997;91:961–971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9428519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mitchelhill KI, et al.  Posttranslational modifications of the 5'-AMP-activated protein kinase beta1 subunit. J. Biol. Chem. 1997;272:24475–24479.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9305909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley SA, et al.  Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells. Biochem. J. 2014;459:275–287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4052680</ArticleId>
            <ArticleId IdType="pubmed">24467442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuerk RD, et al.  Tracking and quantification of 32P-labeled phosphopeptides in liquid chromatography matrix-assisted laser desorption/ionization mass spectrometry. Anal. Biochem. 2009;390:141–148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19376078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egan DF, et al.  Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011;331:456–461.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3030664</ArticleId>
            <ArticleId IdType="pubmed">21205641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mihaylova MM, et al.  Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell. 2011;145:607–621.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3117637</ArticleId>
            <ArticleId IdType="pubmed">21565617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeRan M, et al.  Energy stress regulates Hippo-YAP signaling involving AMPK-mediated regulation of Angiomotin-like 1 protein. Cell Rep. 2014;9:495–503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4223634</ArticleId>
            <ArticleId IdType="pubmed">25373897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marin TL, et al.  Identification of AMP-activated protein kinase targets by a consensus sequence search of the proteome. BMC Syst. Biol. 2015;9:13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4357066</ArticleId>
            <ArticleId IdType="pubmed">25890336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ducommun S, et al.  Motif affinity and mass spectrometry proteomic approach for the discovery of cellular AMPK targets: Identification of mitochondrial fission factor as a new AMPK substrate. Cell. Signal. 2015;27:978–988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25683918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obenauer JC, et al.  Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucl. Acids Res. 2003;31:3635–3641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC168990</ArticleId>
            <ArticleId IdType="pubmed">12824383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grant CE, et al.  FIMO: scanning for occurrences of a given motif. Bioinformatics. 2011;27:1017–1018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3065696</ArticleId>
            <ArticleId IdType="pubmed">21330290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuerk RD, et al.  New candidate targets of AMP-activated protein kinase in murine brain revealed by a novel multidimensional substrate-screen for protein kinases. J. Proteome Res. 2007;6:3266–3277.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17608512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behrends C, et al.  Network organization of the human autophagy system. Nature. 2010;466:68–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2901998</ArticleId>
            <ArticleId IdType="pubmed">20562859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huttlin EL, et al.  The BioPlex Network: a systematic exploration of the human interactome. Cell. 2015;162:425–440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4617211</ArticleId>
            <ArticleId IdType="pubmed">26186194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goodwin JM, et al.  An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential. Mol. Cell. 2014;55:436–450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4151130</ArticleId>
            <ArticleId IdType="pubmed">25042806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michell BJ, et al.  Isoform-specific purification and substrate specificity of the 5'-AMP-activated protein kinase. J. Biol. Chem. 1996;271:28445–28450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8910470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie DG. Regulation of AMP-activated protein kinase by natural and synthetic activators. Acta Pharm. Sin. B. 2015 in press.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4724661</ArticleId>
            <ArticleId IdType="pubmed">26904394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crooks GE, et al.  WebLogo: a sequence logo generator. Genome Res. 2004;14:1188–1190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC419797</ArticleId>
            <ArticleId IdType="pubmed">15173120</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
